A major collaboration between Manchester and the National Institute for Health and Care Excellence (NICE) was renewed for a further three years in 2014.
Following the initial Memorandum of Understanding, signed in 2011 by NICE, MAHSC and The University of Manchester, significant achievements were made in contributing to the assessment of new drugs and medical technologies, and supporting development of new treatment guidelines and quality standards for conditions ranging from cancer and diabetes to heart disease and psoriasis.
NICE and MAHSC share a commitment to improving the overall health of the population, through informing health policy and practice and in developing and evaluating health technologies. MAHSC is dedicated to translating research discoveries into new patient treatments, identifying unmet clinical need and applying research and innovation to meeting this need, and delivering improved patient care through its NHS partners. The University of Manchester is the lead research and teaching member for MAHSC.
Key collaborative successes to date include:
- Manchester Pharmacy School developing a series of 20 e-learning tools for NICE.
- Clinical and research experts joining NICE teams appraising new drugs and diagnostic testing for lung cancer and developing guidelines for the treatment of Non-Hodgkin lymphoma.
- Contributing to the development of NICE guidelines and quality standards for treating patients with psoriasis and colorectal cancer.
- Taking part in the NICE advisory panel on new medical technologies and appraising new diagnostic tools.
- Creating the North West Evidence Synthesis Network to share ideas on how to assess evidence relating to research findings and treatments, and so help to inform policy and decision making in the NHS.
- NICE colleagues appointed as honorary University staff and helping to develop and deliver postgraduate training courses in evidence based population health, communicable disease control and public health leadership.
The new Memorandum of Understanding is particularly focused on health technologies and public health, drawing on both NICE’s expertise and a number of MAHSC programmes and University research groupings including: the MAHSC Population Health Domain, University Institute of Population Health, Manchester: Integrating Medicine and Innovative Technology (MIMIT), Manchester Health E-Research Centre and Farr Institute, NorthWest EHealth (NWEH), NIHR Greater Manchester Collaboration for Leadership in Applied Health Research and Care (CLAHRC) and Nowgen.
An early area of work under the new Memorandum is focused on developing an early stage assessment tool to help companies, particularly SMEs, understand how best to prepare for working with NICE and to develop an evidence base for their technologies.
Read more about the MoU and what has been achieved to date in our Working in partnership with NICE report.